These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17885327)

  • 1. Maintaining the standard: a quality assurance study for new equipment in the Michigan ECMO Program.
    Fleming GM; Gupta M; Cooley E; Remenapp R; Bartlett RH; Annich GM
    ASAIO J; 2007; 53(5):556-60. PubMed ID: 17885327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New technology, old standards: disparate activated clotting time measurements by the Hemochron Jr compared with the standard Hemochron.
    Aylsworth CL; Stefan F; Woitas K; Rieger RH; LeBoutillier M; DiSesa VJ
    Ann Thorac Surg; 2004 Mar; 77(3):973-6. PubMed ID: 14992909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: Hemochron Junior Low Range versus Hemochron 400.
    Colby CE; Sheehan A; Benitz W; Van Meurs K; Halamek LP; Moss RL
    J Extra Corpor Technol; 2003 Mar; 35(1):35-8. PubMed ID: 12680494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques.
    Mabry CD; Thompson BW; Read RC; Campbell GS
    Surgery; 1981 Nov; 90(5):889-95. PubMed ID: 7302842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival.
    Baird CW; Zurakowski D; Robinson B; Gandhi S; Burdis-Koch L; Tamblyn J; Munoz R; Fortich K; Pigula FA
    Ann Thorac Surg; 2007 Mar; 83(3):912-9; discussion 919-20. PubMed ID: 17307433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques.
    Carter AJ; Hicks K; Heldman AW; Resar JR; Laird JR; Coombs VJ; Brinker JA; Blumenthal RS
    Cathet Cardiovasc Diagn; 1996 Sep; 39(1):97-102. PubMed ID: 8874958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
    O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
    ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of 99 patients with the application of extracorporeal membrane oxygenation in Fuwai Hospital.
    Yuan Y; Gao G; Long C; Hei F; Li J; Liu J; Feng Z; Yu K; Zhao J; Lrou S; Hu S; Chang Q; Liu Y; Xu J; Wang X; Liu P
    ASAIO J; 2009; 55(5):474-7. PubMed ID: 19701084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.
    Chia S; Van Cott EM; Raffel OC; Jang IK
    Thromb Haemost; 2009 Mar; 101(3):535-40. PubMed ID: 19277416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged extracorporeal circulation without heparin. Evaluation of the Medtronic Minimax oxygenator.
    Shanley CJ; Hultquist KA; Rosenberg DM; McKenzie JM; Shah NL; Bartlett RH
    ASAIO J; 1992; 38(3):M311-6. PubMed ID: 1457872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass.
    Welsby IJ; McDonnell E; El-Moalem H; Stafford-Smith M; Toffaletti JG
    J Clin Monit Comput; 2002 Jul; 17(5):287-92. PubMed ID: 12546261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interchangeability of activated clotting time values across different point-of-care systems.
    Thenappan T; Swamy R; Shah A; Nathan S; Nichols J; Bond L; Jolly N
    Am J Cardiol; 2012 May; 109(9):1379-82. PubMed ID: 22341924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a bedside activated clotting time test (Hemochron Jr II Signature) with low dose heparin therapy.
    Racioppi L; Quinart A; Biais M; Nouette-Gaulain K; Revel P; Sztark F
    Anaesthesia; 2009 Apr; 64(4):430-4. PubMed ID: 19317710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive performance of three methods of activated clotting time measurement in neonatal ECMO patients.
    Seay RE; Uden DL; Kriesmer PJ; Payne NR
    ASAIO J; 1993; 39(1):39-42. PubMed ID: 8439678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical component failures in 28,171 neonatal and pediatric extracorporeal membrane oxygenation courses from 1987 to 2006.
    Fleming GM; Gurney JG; Donohue JE; Remenapp RT; Annich GM
    Pediatr Crit Care Med; 2009 Jul; 10(4):439-44. PubMed ID: 19307816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
    Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedural variables which affect activated clotting time test results during extracorporeal membrane oxygenation therapy.
    Uden DL; Payne NR; Kriesmer P; Cipolle RJ
    Crit Care Med; 1989 Oct; 17(10):1048-51. PubMed ID: 2791566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a new whole blood coagulation monitoring system.
    Jaryno S; Bennett K; Loder C; Zucker ML; Pan CM; LaDuca FM
    J Extra Corpor Technol; 2002 Dec; 34(4):271-5. PubMed ID: 12533064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carmeda surface heparinization in neonatal ECMO systems: long-term experiments in a sheep model.
    Palmer K; Ehrén H; Benz R; Frenckner B
    Perfusion; 1995 Sep; 10(5):307-13. PubMed ID: 8601042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation.
    Nankervis CA; Preston TJ; Dysart KC; Wilkinson WD; Chicoine LG; Welty SE; Nelin LD
    ASAIO J; 2007; 53(1):111-4. PubMed ID: 17237658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.